Refresh

Genpharmasec Ltd. - Research Center

531592 GENPHARMA Group (XT) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

30.41 25.52 27.32 21.31 16.50
Expenses

Material consumed

24.22 23.40 26.57 19.20 15.24

Manufacturing expenses

0.01 - - - -

Personnel expenses

0.76 0.54 0.25 0.19 0.13

Selling expenses

- - - - -

Adminstrative expenses

5.25 1.32 1.02 0.73 0.49

Expenses capitalised

- - - - -

Cost of sales

30.25 25.26 27.84 20.11 15.85

Operating profit

0.16 0.26 -0.52 1.19 0.65

Other recurring income

0.72 0.10 0.09 0.33 0.56

Adjusted PBDIT

0.88 0.36 -0.43 1.52 1.21

Financial expenses

0.39 0.06 - - -

Depreciation

0.02 0.02 0.01 0.01 -

Other write offs

- - - - -

Adjusted PBT

0.47 0.28 -0.44 1.51 1.21

Tax charges

0.42 -0.84 -0.23 0.25 0.20

Adjusted PAT

0.05 1.12 -0.21 1.26 1.01

Non recurring items

- -0.82 - - -

Other non cash adjustments

- - - - -

Reported net profit

0.05 0.30 -0.21 1.26 1.01

Earnigs before appropriation

-4.52 -4.57 1.10 1.31 0.05

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-4.52 -4.57 1.10 1.31 0.05
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com